Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Australia-based Inventia Life Science opens first U.S. location 

By Brian Buntz | October 18, 2022

InventiaThe Australian biotech Inventia Life Science has opened an office and facility in Wilmington, Delaware.

The new location is based at the Innovation Space, which offers lab space and resources to science startups.

Inventia Life Science had investigated a handful of other regions before settling on Delaware, including Philadelphia, San Diego and Texas.

The bioprinting company has also hired its first U.S. employee, Dwayne Dexter as director of sales and operations. Dexter has a Ph.D. in cellular and molecular biology.

Inventia Life Science recently won AU$35 million in Series B funding. The company has won approximately AU$45 million to date.

Inventia's Rastrum

Inventia’s Rostrum [Image courtesy of Inventia Life Science]

Inventia focuses on creating life-like 3D human tissues for drug and therapy research. The company’s Rastrum 3D cell culture platform can be used for a variety of biomedical applications including testing new drugs in a 3D cellular environment. According to the company, the testing platform can help drug developers weed out drug candidates that are ill suited for clinical trials.

Inventia notes that more than 90% of drug candidates fail in human clinical studies.

Founded in 2013, the company is headquartered in Sydney, Australia.

Its Series B fundraising round has enabled the company to launch its Rastrum product in the U.S.

Inventia has “seen a strong international demand from leading research institutes and top 10 global pharmaceutical companies for Rastrum – four of which use Rastrum for their drug discovery programs,” Dexter said in a press release.

Dexter previously worked as the director of U.S. operations at Mimetas, which provides organ-on-a-chip technology.

The Innovation Stations is based at the DuPont Experimental Station campus, which is a storied collection of research and development laboratories founded in 1903.

In 2020, Inventia won Fast Company’s Changing Ideas Award for experimental science.

Under its Inventia Skin umbrella, the company is also working on skin regeneration.


Filed Under: Drug Discovery and Development
Tagged With: Inventia Life Sciences
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

Collage of close-up male and female eyes isolated on colored neon backgorund. Multicolored stripes. Concept of equality, unification of all nations, ages and interests. Diversity and human rights
How a ‘rising tide’ of inclusivity is transforming clinical trials
Mary Marcus appointed CEO of NewAge Industries
DNA double helix transforming into bar graphs, blue and gold, crisp focus on each strand, scientific finance theme --ar 5:4 --personalize 3kebfev --v 6.1 Job ID: f40101e1-2e2f-4f40-8d57-2144add82b53
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
Data analytics tools help doctors analyze trends in patient outcomes and population health.
External comparator studies: What researchers need to know to minimize bias
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE